微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 43.63% | 2.95% | -1.12% | 14/51 | 35.76% | 南华生物 | 68.03% | 行业排名> |
| 2024-06-30 | 44.13% | 0.87% | 1.89% | 15/51 | 35.89% | 百诚医药 | 68.75% | 行业排名> |
| 2024-03-31 | 43.31% | 7.58% | 2.19% | 16/51 | 35.75% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 42.38% | 1.52% | -0.01% | 23/51 | 38.13% | 药康生物 | 67.61% | 行业排名> |
| 2023-09-30 | 42.38% | -32.4% | -3.12% | 24/51 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 43.74% | 5.53% | 8.66% | 18/51 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 40.26% | -19.31% | -3.56% | 24/51 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 41.74% | -31.42% | 0.7% | 24/51 | 40.1% | 药康生物 | 71.38% | 行业排名> |
| 2022-06-30 | 41.45% | -34.97% | -16.92% | 27/51 | 39.96% | 药康生物 | 73.27% | 行业排名> |
| 2022-03-31 | 49.89% | 2% | -18.03% | 9/51 | 38.57% | 药康生物 | 75.32% | 行业排名> |
| 2021-12-31 | 60.86% | 4.68% | -2.92% | 4/51 | 41.94% | 药康生物 | 76.7% | 行业排名> |
| 2021-09-30 | 62.7% | 2% | -1.64% | 4/51 | 43.07% | 药康生物 | 74.33% | 行业排名> |
| 2021-06-30 | 63.74% | 14.96% | 9.63% | 5/51 | 42.6% | 南华生物 | 84.53% | 行业排名> |
| 2020-12-31 | 58.14% | 15.03% | 4.87% | 6/51 | 38.51% | 南华生物 | 83.19% | 行业排名> |
| 2020-06-30 | 55.45% | -3.08% | 9.7% | 7/51 | 39.28% | 南华生物 | 83.9% | 行业排名> |
| 2019-12-31 | 50.55% | 14.03% | 14.03% | 12/51 | 42.94% | 成都先导 | 79.36% | 行业排名> |
| 2018-12-31 | 44.32% | -5.08% | -22.52% | 18/51 | 42.09% | 成都先导 | 75.92% | 行业排名> |
| 2018-06-30 | 57.21% | 2% | 22.5% | 3/51 | 43.98% | 南华生物 | 78.74% | 行业排名> |
| 2017-12-31 | 46.7% | 2% | 2% | 12/51 | 40.94% | 成都先导 | 80.82% | 行业排名> |